Abstracts (HTML) List of Authors

Danese, S

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study
Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Danzinger, D

Endoskopische Raritäten

Datz, C

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study
Gastroenterologist against the machine - opportunities and limitations of machine learning models for prediction of advanced adenoma
NAFLD is not independently associated with H. pylori in an Austrian screening collective
PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center
PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population

Datz, L

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

Dax, K

Listeria-associated multiple granulomatous liver abscesses complicated by vena cava inferior thrombosis
COVID-19 vaccination in patients with autoimmune hepatitis
COVID19 vaccination in liver transplant recipients
Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Dejaco, C

Heart rate variability in patients with irritable bowel syndrome before and after gut-directed hypnotherapy: a preliminary study.

De Toni, E

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Dinkhauser, P

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASEIBDstudy)

Dorn, L

Secondary Sclerosing Cholangitis of the Critically Ill Patient suffering from COVID19

Dossa, SDe

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Duller, C

ERCP in Österreich: Hat die Zentrumsgröße Einfluss auf Erfolgs- und Komplikationsraten?